1. Home
  2. FENG vs QNCX Comparison

FENG vs QNCX Comparison

Compare FENG & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

HOLD

Current Price

$1.49

Market Cap

18.0M

Sector

Industrials

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$18.99

Market Cap

17.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FENG
QNCX
Founded
1998
2012
Country
China
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.0M
17.1M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
FENG
QNCX
Price
$1.49
$18.99
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
9.3K
168.7K
Earning Date
05-12-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.53
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$0.08
52 Week High
$3.65
$20.72

Technical Indicators

Market Signals
Indicator
FENG
QNCX
Relative Strength Index (RSI) 40.33 84.29
Support Level N/A $0.89
Resistance Level $1.80 $19.26
Average True Range (ATR) 0.04 1.60
MACD -0.00 0.19
Stochastic Oscillator 9.37 69.13

Price Performance

Historical Comparison
FENG
QNCX

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives all of its revenue from PRC.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: